Table of Content

1. Executive Summary


2. Introduction

2.1 Influenza Vaccine: An Overview
2.1.1 Common Symptoms of Influenza Virus

2.2 Influenza Vaccine Segmentation: An Overview
2.2.1 Influenza Vaccine Segmentation


3. Global Market Analysis

3.1 Global Influenza Vaccine Market: An Analysis

3.1.1 Global Influenza Vaccine Market: An Overview
3.1.2 Global Influenza Vaccine Market by Value
3.1.3 Global Influenza Vaccine Market by Valency (Quadrivalent and Trivalent)
3.1.4 Global Influenza Vaccine Market by Vaccine Type (Inactivated and Live Attenuated)
3.1.5 Global Influenza Vaccine Market by Technology (Egg-Based and Cell-Based)
3.1.6 Global Influenza Vaccine Market by Age Group (Adult and Pediatric)
3.1.7 Global Influenza Vaccine Market by Route of Administration (Injection and Nasal Spray)
3.1.8 Global Influenza Vaccine Market by Distribution Channel (Hospitals and Pharmacies, Government and Institutions and Others)
3.1.9 Global Influenza Vaccine Market by Region (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

3.2 Global Influenza Vaccine Market: Valency Analysis

3.2.1 Global Influenza Vaccine Market by Valency: An Overview
3.2.2 Global Quadrivalent Influenza Vaccine Market by Value
3.2.3 Global Trivalent Influenza Vaccine Market by Value

3.3 Global Influenza Vaccine Market: Vaccine Type Analysis

3.3.1 Global Influenza Vaccine Market by Vaccine Type: An Overview
3.3.2 Global Inactivated Influenza Vaccine Market by Value
3.3.3 Global Live Attenuated Influenza Vaccine Market by Value

3.4 Global Influenza Vaccine Market: Technology Analysis

3.4.1 Global Influenza Vaccine Market by Technology: An Overview
3.4.2 Global Egg Based Influenza Vaccine Market by Value
3.4.3 Global Cell Based Influenza Vaccine Market by Value

3.5 Global Influenza Vaccine Market: Age Group Analysis

3.5.1 Global Influenza Vaccine Market by Age Group: An Overview
3.5.2 Global Adult Influenza Vaccine Market by Value
3.5.3 Global Pediatric Influenza Vaccine Market by Value

3.6 Global Influenza Vaccine Market: Route of Administration Analysis

3.6.1 Global Influenza Vaccine Market by Route of Administration: An Overview
3.6.2 Global Injectable Influenza Vaccine Market by Value
3.6.3 Global Nasal Spray Influenza Vaccine Market by Value

3.7 Global Influenza Vaccine Market: Distribution Channel Analysis

3.7.1 Global Influenza Vaccine Market by Distribution Channel: An Overview
3.7.2 Global Hospitals and Pharmacy Influenza Vaccine Market by Value
3.7.3 Global Government and Institutions Influenza Vaccine Market by Value
3.7.4 Global Others Influenza Vaccine Market by Value


4. Regional Market Analysis

4.1 North America Influenza Vaccine Market: An Analysis

4.1.1 North America Influenza Vaccine Market: An Overview
4.1.2 North America Influenza Vaccine Market by Value
4.1.3 North America Influenza Vaccine Market by Region (The US, Canada, Mexico)
4.1.4 The US Influenza Vaccine Market by Value
4.1.5 Canada Influenza Vaccine Market by Value
4.1.6 Mexico Influenza Vaccine Market by Value

4.2 Europe Influenza Vaccine Market: An Analysis

4.2.1 Europe Influenza Vaccine Market: An Overview
4.2.2 Europe Influenza Vaccine Market by Value
4.2.3 Europe Influenza Vaccine Market by Region (Germany, UK, France, Italy, Spain and Rest of Europe)
4.2.4 UK Influenza Vaccine Market by Value
4.2.5 Germany Influenza Vaccine Market by Value
4.2.6 France Influenza Vaccine Market by Value
4.2.7 Italy Influenza Vaccine Market by Value
4.2.8 Spain Influenza Vaccine Market by Value
4.2.9 Rest of Europe Influenza Vaccine Market by Value

4.3 Asia Pacific Influenza Vaccine Market: An Analysis

4.3.1 Asia Pacific Influenza Vaccine Market: An Overview
4.3.2 Asia Pacific Influenza Vaccine Market by Value
4.3.3 Asia Pacific Influenza Vaccine Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
4.3.4 China Influenza Vaccine Market by Value
4.3.5 Japan Influenza Vaccine Market by Value
4.3.6 India Influenza Vaccine Market by Value
4.3.7 South Korea Influenza Vaccine Market by Value
4.3.8 Rest of Asia Pacific Influenza Vaccine Market by Value

4.4 Middle East & Africa Influenza Vaccine Market: An Analysis

4.4.1 Middle East & Africa Influenza Vaccine Market: An Overview
4.4.2 Middle East & Africa Influenza Vaccine Market by Value

4.5 Latin America Influenza Vaccine Market: An Analysis

4.5.1 Latin America Influenza Vaccine Market: An Overview
4.5.2 Latin America Influenza Vaccine Market by Value


5. Impact of COVID-19

5.1 Impact of COVID-19 on Influenza Vaccine Market
5.2 Post COVID-19 Impact on Influenza Vaccine Market


6. Market Dynamics

6.1 Growth Drivers
6.1.1 Increasing Flu Burden among Adult Population
6.1.2 Rapid Urbanization
6.1.3 Rising Prevalence of Influenza Epidemics and Seasonal Outbreaks
6.1.4 Increased Public Health Awareness
6.1.5 Increasing Government Support
6.1.6 Robust Research and Development Investments

6.2 Challenges
6.2.1 Longer Timeline for Vaccine Production
6.2.2 High cost of Vaccine Development
6.2.3 Inequitable Access to Vaccines

6.3 Market Trends
6.3.1 Use of AI in Vaccine Development
6.3.2 Technological Advancements in Vaccine Administration
6.3.3 Shift in Trends towards mRNA-based Flu Vaccine


7. Competitive Landscape

7.1 Global Influenza Vaccine Players by Market Share
7.2 Global Influenza Vaccine Market Players by Vaccines Efficiency and Safety
7.3 Global mRNA Influenza Vaccine Market Players by Vaccines in Clinical Development


8. Company Profiles

8.1 GlaxoSmithKline Plc
8.1.1 Business Overview
8.1.2 Sales by Products
8.1.3 Business Strategies

8.2 Abbott
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies

8.3 Pfizer Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategies

8.4 AstraZeneca Plc
8.4.1 Business Overview
8.4.2 Revenue by Disease Area
8.4.3 Business Strategies

8.5 Sanofi S.A.
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy

8.6 Moderna Inc.
8.6.1 Business Overview
8.6.2 Operating Regions
8.6.3 Business Strategies

8.7 CSL Limited
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategies

8.8 Emergent BioSolutions Inc
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy

8.9 BIKEN Co., Ltd.
8.9.1 Business Overview
8.9.2 Business Strategy

8.10 Serum Institute of India Pvt. Ltd.
8.10.1 Business Overview
8.10.2 Business Strategy

8.11 Sinovac
8.11.1 Business Overview
8.11.2 Business Strategy

8.12 GC Biopharma
8.12.1 Business Overview
8.12.2 Business Strategy

List of Figures

Figure 1: Common Symptoms of Influenza Virus
Figure 2: Influenza Vaccine Segmentation
Figure 3: Global Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Influenza Vaccine Market by Valency; 2022 (Percentage, %)
Figure 6: Global Influenza Vaccine Market by Vaccine Type; 2022 (Percentage, %)
Figure 7: Global Influenza Vaccine Market by Technology; 2022 (Percentage, %)
Figure 8: Global Influenza Vaccine Market by Age Group; 2022 (Percentage, %)
Figure 9: Global Influenza Vaccine Market by Route of Administration; 2022 (Percentage, %)
Figure 10: Global Influenza Vaccine Market by Distribution Channel; 2022 (Percentage, %)
Figure 11: Global Influenza Vaccine Market by Region; 2022 (Percentage, %)
Figure 12: Global Quadrivalent Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 13: Global Quadrivalent Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 14: Global Trivalent Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 15: Global Trivalent Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 16: Global Inactivated Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 17: Global Inactivated Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 18: Global Live Attenuated Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 19: Global Live Attenuated Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 20: Global Egg Based Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 21: Global Egg Based Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 22: Global Cell Based Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 23: Global Cell Based Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 24: Global Adult Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 25: Global Adult Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 26: Global Pediatric Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 27: Global Pediatric Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 28: Global Injectable Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 29: Global Injectable Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 30: Global Nasal Spray Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 31: Global Nasal Spray Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 32: Global Hospitals and Pharmacy Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 33: Global Hospitals and Pharmacy Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 34: Global Government and Institutions Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 35: Global Government and Institutions Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 36: Global Others Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 37: Global Others Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 38: North America Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 39: North America Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 40: North America Influenza Vaccine Market by Region; 2022 (Percentage, %)
Figure 41: The US Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 42: The US Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 43: Canada Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 44: Canada Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 45: Mexico Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 46: Mexico Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 47: Europe Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 48: Europe Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 49: Europe Influenza Vaccine Market by Region; 2022 (Percentage, %)
Figure 50: UK Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 51: UK Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 52: Germany Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 53: Germany Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 54: France Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 55: France Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 56: Italy Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 57: Italy Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 58: Spain Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 59: Spain Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 60: Rest of Europe Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 61: Rest of Europe Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 62: Asia Pacific Influenza Vaccine Market by Value; 2018-2022 (US$ Billion)
Figure 63: Asia Pacific Influenza Vaccine Market by Value; 2023-2028 (US$ Billion)
Figure 64: Asia Pacific Influenza Vaccine Market by Region; 2022 (Percentage, %)
Figure 65: China Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 66: China Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 67: Japan Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 68: Japan Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 69: India Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 70: India Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 71: South Korea Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 72: South Korea Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 73: Rest of Asia Pacific Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 74: Rest of Asia Pacific Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 75: Middle East & Africa Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 76: Middle East & Africa Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 77: Latin America Influenza Vaccine Market by Value; 2018-2022 (US$ Million)
Figure 78: Latin America Influenza Vaccine Market by Value; 2023-2028 (US$ Million)
Figure 79: The US Flu Disease Burden by Age Group; 2021-2022 Flu Season (Percentage, %)
Figure 80: Global Urban Population; 2016, 2021 & 2050 (Billion)
Figure 81: Global Market Size for Artificial Intelligence in Healthcare; 2021-2030 (US $Billion)
Figure 82: Global Influenza Vaccine Players by Market Share; 2022 (Percentage, %)
Figure 83: GlaxoSmithKline Plc Sales by Products; 2022 (Percentage, %)
Figure 84: Abbott Sales by Segments; 2022 (Percentage, %)
Figure 85: Pfizer Inc. Revenue by Segment; 2022 (Percentage, %)
Figure 86: AstraZeneca Total Revenue by Disease Areas; 2022 (Percentage, %)
Figure 87: Sanofi S.A. Net Sales by Segments; 2022 (Percentage, %)
Figure 88: Moderna Inc. Total Revenue by Geographic Area; 2022 (Percentage, %)
Figure 89: CSL Limited Revenue by Segments; 2022 (Percentage, %)
Figure 90: Emergent BioSolutions Revenue by Segments; 2022 (Percentage, %)
Table 1: Global Influenza Vaccine Market Players by Vaccine Efficiency and Safety Comparison
Table 2: Global mRNA Influenza Vaccine Market Players by Vaccines in Clinical Development